Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2022 Apr 19:13:874975.
doi: 10.3389/fendo.2022.874975. eCollection 2022.

Effect of Levothyroxine on Pregnancy Outcomes in Pregnant Women With Hypothyroxinemia: An Interventional Study

Guohua Li  1 , Yang Liu  2 , Xiujuan Su  3 , Shijia Huang  2 , Xiaosong Liu  2 , Qiaoling Du  2
Affiliations
Clinical Trial

Effect of Levothyroxine on Pregnancy Outcomes in Pregnant Women With Hypothyroxinemia: An Interventional Study

Guohua Li et al. Front Endocrinol (Lausanne). .

Abstract

Context: Adverse maternal outcomes and perinatal complications are associated with maternal hypothyroidism. However, the utility of levothyroxine (L-T4) in the treatment of pregnant women with hypothyroxinemia is unclear.

Objective: This study aimed to evaluate the effects of L-T4 on maternal and perinatal outcomes in pregnant women with hypothyroxinemia.

Methods: The nonrandomized interventional study was conducted at Shanghai First Maternity and Infant Hospital, Punan Hospital of Shanghai, and Beicai Community Health Center of Shanghai. The pregnant women with hypothyroxinemia from the first trimester were enrolled and divided into treatment and control groups. 463 taking L-T4 and 501 not administering L-T4 were analyzed in the study. All participants were screened for TPOAB/TGAB antibody status.

Main outcome: The primary outcome of the study was the hypertensive disorder of pregnancy (HDP), measured as the proportion of HDP. In addition to this primary outcome, some secondary outcomes will be measured: miscarriage, gestational diabetes mellitus, premature rupture of membranes, placental abruption, intrahepatic cholestasis of pregnancy, fetal distress, macrosomia, and neonates admitted to the neonatal intensive care unit (NICU). The effects of L-T4 on the incidence of adverse pregnancy outcomes and perinatal complications were compared.

Results: Multivariate logistic regression analysis showed that L-T4 treatment (adjusted odds ratio = 1.78 [95% CI = 1.00-3.16], p = 0.04) significantly reduced the incidence of miscarriage. Otherwise, lower neonates admitted to the NICU were strongly associated with the L-T4 group (adjusted odds ratio = 1.36 [95% CI = 1.01 - 1.83], p = 0.04). There were no significant differences in the incidence rates of other adverse maternal outcomes and perinatal complications between pregnant women with hypothyroxinemia receiving and those not receiving L-T4 treatment.

Conclusion: The incidence of HDP was not significantly reduced using L-T4 in pregnant women with hypothyroxinemia. The results of this study also showed that L-T4 treatment significantly reduced the miscarriages rate and the proportion of newborns admitted to the NICU.

Keywords: hypertensive disorder of pregnancy; hypothyroxinemia; levothyroxine; maternal outcomes; miscarriage.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the study population.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Laurberg P, Andersen SL, Pedersen IB, Andersen S, Carlé A. Screening for Overt Thyroid Disease in Early Pregnancy may be Preferable to Searching for Small Aberrations in Thyroid Function Tests. Clin Endocrinol (2013) 79(3):297–304. doi: 10.1111/cen.12232 - DOI - PubMed
    1. Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, et al. . Global Causes of Maternal Death: A WHO Systematic Analysis. Lancet Glob Health (2014) 2(6):e323–33. doi: 10.1016/S2214-109X(14)70227-X - DOI - PubMed
    1. Wilson KL, Casey BM, McIntire DD, Halvorson LM, Cunningham FG. Subclinical Thyroid Disease and the Incidence of Hypertension in Pregnancy. Obstet Gynecol (2012) 119(2 Part 1):315–20. doi: 10.1097/AOG.0b013e318240de6a - DOI - PubMed
    1. Buimer M, van Wassenaer AG, Ganzevoort W, Wolf H, Bleker OP, Kok JH. Transient Hypothyroxinemia in Severe Hypertensive Disorders of Pregnancy. Obstet Gynecol (2005) 106(5 Part 1):973–9. doi: 10.1097/01.AOG.0000180395.06136.b5 - DOI - PubMed
    1. Levine RJ, Vatten LJ, Horowitz GL, Qian C, Romundstad PR, Yu KF, et al. . Pre-Eclampsia, Soluble Fms-Like Tyrosine Kinase 1, and the Risk of Reduced Thyroid Function: Nested Case-Control and Population Based Study. BMJ (2009) 339:b4336. doi: 10.1136/bmj.b4336 - DOI - PMC - PubMed

Publication types